Literature DB >> 10924172

Hermitamides A and B, toxic malyngamide-type natural products from the marine cyanobacterium Lyngbya majuscula.

L T Tan1, T Okino, W H Gerwick.   

Abstract

A Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula yielded two new and toxic natural products, hermitamides A (1) and B (2). The hermitamides were isolated using a brine shrimp (Artemia salina) toxicity assay. Planar chemical structures of 1 and 2 were established through 1D and 2D NMR, as well as FABMS data. Semisyntheses of hermitamides A (1) and B (2) were achieved by coupling the acid chloride derivative of 7(S)-methoxytetradec-4(E)-enoic acid (4), obtained from the same cyanobacterium collection, and the respective free amines, phenethylamine and tryptamine. Hermitamides A (1) and B (2) exhibited LD(50) values of 5 microM and 18 microM in the brine shrimp bioassay, and an IC(50) values of 2.2 microM and 5.5 microM to Neuro-2a neuroblastoma cells in tissue culture, respectively. Hermitamide A was mildly ichthyotoxic to goldfish, with an LD(50) value of 19 microM, while hermitamide B was inactive at 25 microM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924172     DOI: 10.1021/np000037x

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  15 in total

1.  Credneramides A and B: neuromodulatory phenethylamine and isopentylamine derivatives of a vinyl chloride-containing fatty acid from cf. Trichodesmium sp. nov.

Authors:  Karla L Malloy; Takashi L Suyama; Niclas Engene; Hosana Debonsi; Zhengyu Cao; Teatulohi Matainaho; Carmenza Spadafora; Thomas F Murray; William H Gerwick
Journal:  J Nat Prod       Date:  2011-12-12       Impact factor: 4.050

2.  Synthesis and evaluation of hermitamides A and B as human voltage-gated sodium channel blockers.

Authors:  Eliseu O De Oliveira; Kristin M Graf; Manoj K Patel; Aparna Baheti; Hye-Sik Kong; Linda H MacArthur; Sivanesan Dakshanamurthy; Kan Wang; Milton L Brown; Mikell Paige
Journal:  Bioorg Med Chem       Date:  2011-05-30       Impact factor: 3.641

3.  The enantioselective synthesis and biological evaluation of chimeric promysalin analogs facilitated by diverted total synthesis.

Authors:  Kyle W Knouse; William M Wuest
Journal:  J Antibiot (Tokyo)       Date:  2016-02-10       Impact factor: 2.649

Review 4.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

5.  Ketoreductase Domain Dysfunction Expands Chemodiversity: Malyngamide Biosynthesis in the Cyanobacterium Okeania hirsuta.

Authors:  Nathan A Moss; Tiago Leão; Michael R Rankin; Tyler M McCullough; Pingping Qu; Anton Korobeynikov; Janet L Smith; Lena Gerwick; William H Gerwick
Journal:  ACS Chem Biol       Date:  2018-12-03       Impact factor: 5.100

Review 6.  Recent progress in neuroactive marine natural products.

Authors:  Ryuichi Sakai; Geoffrey T Swanson
Journal:  Nat Prod Rep       Date:  2014-01-17       Impact factor: 13.423

7.  Selective MyD88-dependent pathway inhibition by the cyanobacterial natural product malyngamide F acetate.

Authors:  Francisco A Villa; Kelly Lieske; Lena Gerwick
Journal:  Eur J Pharmacol       Date:  2009-12-16       Impact factor: 4.432

Review 8.  Biosynthesis and function of polyacetylenes and allied natural products.

Authors:  Robert E Minto; Brenda J Blacklock
Journal:  Prog Lipid Res       Date:  2008-03-13       Impact factor: 16.195

9.  Isolation, structure elucidation, and synthesis of eudistomides A and B, lipopeptides from a Fijian ascidian Eudistoma sp.

Authors:  Emily L Whitson; Anokha S Ratnayake; Tim S Bugni; Mary Kay Harper; Chris M Ireland
Journal:  J Org Chem       Date:  2009-02-06       Impact factor: 4.354

10.  Pitiamides A and B, Multifunctional Fatty Acid Amides from Marine Cyanobacteria.

Authors:  Weijing Cai; James H Matthews; Valerie J Paul; Hendrik Luesch
Journal:  Planta Med       Date:  2016-05-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.